Principal Financial Group Inc Lineage Cell Therapeutics, Inc. Transaction History

Principal Financial Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$0.8 - $1.12 $4,461 - $6,246	-5,577 Reduced 28.93%	13,700 $12,000
Q2 2024 Jul 29, 2024	BUY	$0.89 - $1.47 $1,269 - $2,096	1,426 Added 7.99%	19,277 $19,000
Q1 2024 Apr 29, 2024	BUY	$0.86 - $1.48 $1,320 - $2,273	1,536 Added 9.41%	17,851 $26,000
Q4 2023 Feb 07, 2024	BUY	$0.91 - $1.35 $982 - $1,458	1,080 Added 7.09%	16,315 $17,000
Q2 2023 Aug 07, 2023	BUY	$1.26 - $1.53 $19,196 - $23,309	15,235 New	15,235 $21,000
Q3 2022 Nov 09, 2022	SELL	$1.13 - $1.77 $29,524 - $46,246	-26,128 Reduced 63.63%	14,937 $17,000
Q2 2022 Aug 10, 2022	SELL	$1.12 - $1.61 $4,585 - $6,591	-4,094 Reduced 9.07%	41,065 $65,000
Q1 2022 May 09, 2022	SELL	$1.21 - $2.48 $40,635 - $83,285	-33,583 Reduced 42.65%	45,159 $70,000
Q4 2021 Feb 09, 2022	SELL	$1.84 - $2.68 $83,677 - $121,878	-45,477 Reduced 36.61%	78,742 $193,000
Q3 2021 Nov 09, 2021	SELL	$2.26 - $2.86 $10,278 - $13,007	-4,548 Reduced 3.53%	124,219 $313,000
Q2 2021 Aug 10, 2021	BUY	$2.17 - $3.0 $279,424 - $386,301	128,767 New	128,767 $366,000
Q2 2020 Aug 05, 2020	SELL	$0.71 - $1.18 $7,110 - $11,817	-10,015 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$0.6 - $1.58 $6,009 - $15,823	10,015 New	10,015 $8,000
Q4 2019 Feb 05, 2020	SELL	$0.54 - $1.01 $6,170 - $11,541	-11,427 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.85 - $1.24 $9,712 - $14,169	11,427 New	11,427 $11,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $95.1M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.